Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
-
Aquinox Announces Closing of $75.4 Million Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Aquinox Pharma (AQXP) Prices 5.35M Common Stock Offering at $12.25/Share
-
Aquinox Prices Public Offering of Common Stock
-
Aquinox Pharma (AQXP) Plans Common Stock Offering
-
Aquinox Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
Aquinox to Present at Canaccord Genuity 36th Annual Growth Conference
-
Aquinox Pharmaceuticals Reports Third Quarter 2015 Financial Results
-
Aquinox Pharmaceuticals Reports Third Quarter 2015 Financial Results
-
Aquinox Announces Closing of $98.0 Million Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Aquinox Announces Closing of $98.0 Million Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Canaccord Genuity Raises Price Target on Aquinox Pharma (AQXP) to $22 on Supporting Evidence for AQX-1125
-
Aquinox Pharma (AQXP) 5.5M Offering Common Stock Prices at $15.50/Share
-
Aquinox Prices Public Offering of Common Stock
-
Aquinox Prices Public Offering of Common Stock
-
Aquinox Pharma (AQXP) Announces $75M Common Stock Offering
-
Aquinox Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
Aquinox Pharmaceuticals to Present at the Canaccord Genuity 35th Annual Growth Conference
-
Aquinox Pharmaceutical (AQXP) PT Lifted to $17 at Canaccord Genuity
-
Aquinox Pharmaceuticals Announces Year End 2014 Financial Results
-
Aquinox Pharmaceuticals Announces Year End 2014 Financial Results
-
Aquinox Pharmaceuticals to Present at Canaccord Genuity 34th Annual Growth Conference
-
Aquinox Pharmaceuticals Announces Closing of Initial Public Offering
-
Aquinox Pharmaceuticals (AQXP) IPO Opens Higher
-
Aquinox Pharmaceuticals (AQXP) IPO Prices at $11
-
Aquinox Pharmaceuticals Prices Initial Public Offering

